| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 8 |
| 1 | ARIPIPRAZOLE | 5 |
| 2 | HALOPERIDOL | 5 |
| 3 | HALOPERIDOL LACTATE | 5 |
| 4 | OLANZAPINE | 5 |
| 5 | ARIPIPRAZOLE ORAL | 4 |
| 6 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 4 |
| 7 | BUPRENORPHINE | 3 |
| 8 | PEMBROLIZUMAB | 3 |
| 9 | BUPRENORPHINE HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 1 | 0.0014 |
| 1 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 2 | HALOPERIDOL LACTATE | 5 | 0.0002 |
| 3 | ZOLMITRIPTAN | 1 | 0.0001 |
| 4 | FREMANEZUMAB-VFRM | 1 | 0.0001 |
| 5 | OLANZAPINE | 5 | 0.0001 |
| 6 | CLOZAPINE | 8 | 0.0001 |
| 7 | ARIPIPRAZOLE | 5 | 0.0000 |
| 8 | BUPRENORPHINE | 3 | 0.0000 |
| 9 | PEMBROLIZUMAB | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 5 | 0.0002 |
| 1 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 2 | Partial Opioid Agonist [EPC] | 3 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 4 | Atypical Antipsychotic [EPC] | 8 | 0.0000 |
| 5 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 1 | 0.0000 |